We are thrilled to announce that Cleo, the groundbreaking AI platform dedicated to transforming the relationship people have with their finances, has successfully raised $80 million in Series C funding, led by Sofina, bringing the company’s valuation to an impressive $500 million. Founded in 2016 by a team frustrated with the traditional banking system, Cleo has rapidly evolved into a powerful tool for the 99%, providing a refreshing take on financial management that goes well beyond basic budgeting and saving. Our mission is straightforward—empower individuals to take control of their financial futures through personalized insights and engaging financial tools that bring laughter into the sometimes daunting world of money. This new investment will enable us to enhance our platform, deepen our AI capabilities, and expand our reach to millions more users who deserve a witty and supportive financial ally. Over the past year, we've seen extraordinary growth, doubling our team from 100 to over 250 as we strive to create an inclusive environment where every voice matters. This funding not only fuels our growth but also fortifies our commitment to fostering unbiased financial development for all. We are steadfastly working towards a future where financial well-being is within everyone's reach, using simplicity and humor to break down barriers. Join us on this journey, as we continue to redefine what it means to engage with money in a meaningful way. Together, we can change the narrative and ensure everyone has the tools they need to thrive financially.
Cleo Secures $80 Million in Series C Funding to Transform Financial Well-Being with AI Intelligence
Get the full Cleo company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Lassie
Lassie enables doctors to focus on patients, not paperwork. The average practice spends around 200 hours a month running itself. We have seen firsthand how the administrative burden is quietly breaking independent healthcare. Doctors work late into the night so that they can get through all of their paperwork by hand. Nobody taught them how to submit a claim, bill a patient, or reconcile insurance payments. Our goal is to enable these businesses to run themselves. Lassie works autonomously, around the clock, reading insurance claims, reconciling payments, handling denials and appeals. Over 700 practices across 49 states trust Lassie to run their operations. In the past year alone, we have saved more than 250,000 hours of labor, time redirected entirely to patient care. Learn more or join the team: lassie.ai
$35.0M Unknown
today
GR3N SA
GR3N SA is a Swiss company founded in 2011 that developed an innovative process, based on the application of microwave technology to an alkaline hydrolysis, which provides an economically viable recycling process of Polyethylene Terephthalate (PET), allowing the industrial implementation. This new process can potentially change how PET is recycled worldwide, with huge benefits both for the recycling industry and for all the polyester value chain. In the past, many efforts were made to transfer chemical recycling from research labs to industry but the economic aspects blocked the proposed solutions. Thanks to the DEMETO (Depolymerization by MicrowavE TechnolOgy) technology developed by gr3n this approach becomes real. gr3n has a massive advantage with respect to its competitors because it can supply a chemical recycling solution (i.e., closing the PET lifecycle, offering polymer grade material, treating waste, lowering carbon footprint) providing cost savings for players in the value chain. The input materials for the process can be post-consumer and/or post-industrial polyesters, both from bottles (colored, colorless, transparent, opaque) and textile (100% polyester but also with up to 30% of other materials like PU, cotton, polyether-polyurea, etc.). The reaction output is a mixture of building block derivatives, which are then isolated and purified. Monomers can be endlessly re-polymerized to provide brand-new virgin PET or any other polymer that is using one of the monomers. As mentioned for the depolymerization step, every time we run a polymerization, we obtain a brand new polymer, where the technical features depend on the monomer purity and the polymerization conditions.
$15.5M Series b
today
phab
phab was born from a single question we’ve asked ourselves for years: why do we have to choose between healthy and tasty? life is complicated as is. our snacks shouldn’t be. ?♂️ and so, with a nutritionist at the helm, scientists by our side, and major foodies in the team, we decided to make snacking superheroes that prove you can have the best of both worlds. ? our mission is to help each of us make that easy switch to better snacking. with 80% of Indians being deficient in protein, we put the macronutrient at the forefront of our protein-powered snack revolution. with phab, you get no trans fats, no GMOs, no harmful sugars, no cutting corners, no BS. just all of the good stuff and none of the guilt. ? our range of products includes: milkshakes + protein, energy and granola bars + protein and superfood bombs + protein powders ?find us in major grocery stores or online marketplaces across India ? learn more at getphab.com ? follow us at instagram.com/getphab
$4.0M Series a
today
Radley Health
RadleyCare’s mission is to enable adults with severe mental illness, and their families, to live amazing lives. Our long term vision is to offer a full suite of psychiatric services to patients, which will improve quality of life and simultaneously decrease the total cost of healthcare. Our entry point is through Peer Recovery Support and Family Peer Support. We couldn't be more excited to bring these valuable services to more people in the State of Ohio. Please join us on our journey to live amazing lives.
$3.0M Seed
today
Arpio
Arpio protects cloud environments from catastrophic events such as outages and ransomware attacks with comprehensive, automated disaster recovery in AWS & Azure.
$15.0M Series a
today